Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1989 Jun;65(764):358–361. doi: 10.1136/pgmj.65.764.358

Visual hallucinations in the elderly associated with the use of levodopa.

A K Banerjee 1, P G Falkai 1, M Savidge 1
PMCID: PMC2429337  PMID: 2692012

Abstract

Visual hallucinations are a well recognized unwanted effect of treatment with levodopa. Although many individual cases have been reported, there has only been one review previously published about this finding, and this did not discriminate age groups. We present five cases and briefly review the literature. It is important to enquire specifically about visual hallucinations in patients on levodopa therapy at follow up, as this otherwise potentially reversible side effect may be overlooked.

Full text

PDF
358

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams K. R., Al-Hamouz S., Edmund E., Tallis R. C., Vellodi C., Lye M. Inappropriate prescribing in the elderly. J R Coll Physicians Lond. 1987 Jan;21(1):39–41. [PMC free article] [PubMed] [Google Scholar]
  2. Caird F. I., Williamson J. Drugs for Parkinson's disease. Lancet. 1978 May 6;1(8071):986–986. doi: 10.1016/s0140-6736(78)90269-6. [DOI] [PubMed] [Google Scholar]
  3. Damãsio A. R., Lobo-Antunes J., Macedo C. Psychiatric aspects in Parkinsonism treated with L-dopa. J Neurol Neurosurg Psychiatry. 1971 Oct;34(5):502–507. doi: 10.1136/jnnp.34.5.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Debono A. G., Donaldson I., Marsden C. D., Parkes J. D. Letter: Bromocriptine in parkinsonism. Lancet. 1975 Nov 15;2(7942):987–988. [PubMed] [Google Scholar]
  5. Jenkins R. B., Groh R. H. Mental symptoms in Parkinsonian patients treated with L-dopa. Lancet. 1970 Jul 25;2(7665):177–179. doi: 10.1016/s0140-6736(70)92535-3. [DOI] [PubMed] [Google Scholar]
  6. Klawans H. L., Jr, Weiner W. J. Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias. J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):427–430. doi: 10.1136/jnnp.37.4.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Koller W. C., Weiner W. J., Perlik S., Nausieda P. A., Goetz C. G., Klawans H. L. Complications of chronic levodopa therapy: long-term efficacy of drug holiday. Neurology. 1981 Apr;31(4):473–476. doi: 10.1212/wnl.31.4.473. [DOI] [PubMed] [Google Scholar]
  8. Lees A. J., Haddad S., Shaw K. M., Kohout L. J., Stern G. M. Bromocriptine in parkinsonism. A long-term study. Arch Neurol. 1978 Aug;35(8):503–505. doi: 10.1001/archneur.1978.00500320023005. [DOI] [PubMed] [Google Scholar]
  9. Moskovitz C., Moses H., 3rd, Klawans H. L. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry. 1978 Jun;135(6):669–675. doi: 10.1176/ajp.135.6.669. [DOI] [PubMed] [Google Scholar]
  10. Nausieda P. A., Glantz R., Weber S., Baum R., Klawans H. L. Psychiatric complications of levodopa therapy of Parkinson's disease. Adv Neurol. 1984;40:271–277. [PubMed] [Google Scholar]
  11. Rabey J. M., Vardi J., Askenazi J. J., Streifler M. L-tryptophan administration in L-dopa-induced hallucinations in elderly Parkinsonian patients. Gerontology. 1977;23(6):438–444. doi: 10.1159/000212220. [DOI] [PubMed] [Google Scholar]
  12. Rondot P., de Recondo J., Coignet A., Ziegler M. Mental disorders in Parkinson's disease after treatment with L-DOPA. Adv Neurol. 1984;40:259–269. [PubMed] [Google Scholar]
  13. Sacks O. W., Messeloff C., Schartz W., Goldfarb A., Kohl M. Effects of L-dopa in patients with dementia. Lancet. 1970 Jun 6;1(7658):1231–1231. doi: 10.1016/s0140-6736(70)91820-9. [DOI] [PubMed] [Google Scholar]
  14. Sharf B., Moskovitz C., Lupton M. D., Klawans H. L. Dream phenomena induced by chronic levodopa therapy. J Neural Transm. 1978;43(2):143–151. doi: 10.1007/BF01579073. [DOI] [PubMed] [Google Scholar]
  15. Sweet R. D., McDowell F. H., Feigenson J. S., Loranger A. W., Goodell H. Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology. 1976 Apr;26(4):305–310. doi: 10.1212/wnl.26.4.305. [DOI] [PubMed] [Google Scholar]
  16. Weiner W. J., Koller W. C., Perlik S., Nausieda P. A., Klawans H. L. Drug holiday and management of Parkinson disease. Neurology. 1980 Dec;30(12):1257–1261. doi: 10.1212/wnl.30.12.1257. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES